| 摘要 |
Disclosed is the use of encapsulated microbial cells in the manufacture of a medicament for treating or preventing of diarrhoea, antibiotic caused diarrhoea, arthritis, obesity, irritable bowel syndrome, heartburn, chronic fatigue syndrome and other forms of suffering from an unbalanced bacterial population in the intestine, or for introducing viable microbial cells into the intestine of an animal, wherein the microbial cells are encapsulated in microcapsules having a porous capsule wall, wherein the porous capsule wall comprises a complex formed from sodium cellulose sulphate and poly[dimethyldiallyl-ammonium chloride], and wherein the microcapsules protect the microbial cells from being degraded by acidic aqueous solution. |
